Last CNY14.63 CNY
Change Today +0.01 / 0.07%
Volume 2.3M
As of 3:00 AM 07/25/14 All times are local (Market data is delayed by at least 15 minutes).

anhui anke biotechnology g-a (300009) Snapshot

Open
CNY14.54
Previous Close
CNY14.62
Day High
CNY14.75
Day Low
CNY14.51
52 Week High
01/8/14 - CNY16.04
52 Week Low
12/3/13 - CNY11.83
Market Cap
4.2B
Average Volume 10 Days
3.2M
EPS TTM
CNY0.32
Shares Outstanding
290.4M
EX-Date
06/6/14
P/E TM
45.3x
Dividend
CNY0.17
Dividend Yield
1.14%
Current Stock Chart for ANHUI ANKE BIOTECHNOLOGY G-A (300009)

Related News

No related news articles were found.

anhui anke biotechnology g-a (300009) Related Businessweek News

No Related Businessweek News Found

anhui anke biotechnology g-a (300009) Details

Anhui Anke Biotechnology (Group) Co., Ltd., together with its subsidiaries, engages in the development, manufacture, and marketing of pharmaceuticals and health-care products in China. It offers interferon alpha 2b for injection, interferon alpha 2b creams, interferon alpha 2b eyedrops, and interferon alpha 2b suppository under the Anterferon name; and growth hormone/somatropin for injection under the Ansomone name. The company also provides monoclonal antibody affinity gel to a-interferon; diagnostic kits; and JIULE branded adefovir dipivoxil tablets. In addition, it offers traditional Chinese medicine and synthetic drugs, including adhesive plasters, oral liquids, ointments, granulation, capsules, tinctures, plasters, syrups, and powders. Further, the company researches and develops recombinant drugs, immunological and diagnosis products, traditional Chinese medicines, pharmaceutical formulations, and chemical medicines. Anhui Anke Biotechnology (Group) Co., Ltd. is based in Hefei, China.

anhui anke biotechnology g-a (300009) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

anhui anke biotechnology g-a (300009) Key Developments

Anhui Anke Biotechnology (Group) Co., Ltd. to Report Q1, 2014 Results on Apr 25, 2014

Anhui Anke Biotechnology (Group) Co., Ltd. announced that they will report Q1, 2014 results on Apr 25, 2014

Anhui Anke Biotechnology (Group) Co., Ltd., Special/Extraordinary Shareholders Meeting, Mar 18, 2014

Anhui Anke Biotechnology (Group) Co., Ltd., Special/Extraordinary Shareholders Meeting, Mar 18, 2014., at 09:30 China Standard Time. Agenda: To consider connected transaction regarding the Company and some of the management members to jointly invest in setting up a controlled company to purchase a product and to conduct research and development; and to acquire partial equity stake of the above controlled company to be set up.

Anhui Anke Biotechnology (Group) Co., Ltd. to Report Fiscal Year 2013 Results on Mar 26, 2014

Anhui Anke Biotechnology (Group) Co., Ltd. announced that they will report fiscal year 2013 results on Mar 26, 2014

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
300009:CH CNY14.63 CNY +0.01

300009 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 300009.
View Industry Companies
 

Industry Analysis

300009

Industry Average

Valuation 300009 Industry Range
Price/Earnings 45.4x
Price/Sales 9.6x
Price/Book 6.3x
Price/Cash Flow 45.6x
TEV/Sales 9.1x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ANHUI ANKE BIOTECHNOLOGY G-A, please visit www.ankebio.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.